Alere Upsizes Term Loan Again, to $925M

Colter, Allison Bisbey
July 2011
High Yield Report;7/4/2011, p9
The article reports on the move by Waltham, Massachusetts-based Alere to expand its term B loan again to 925 million U.S. dollars from 875 million U.S. dollars.


Related Articles

  • Alere Increases Size, Boots Spread on TL. Colter, Allison Bisbey // High Yield Report;7/4/2011, p2 

    The article reports on the move by medical diagnostic manufacturer Alere to expand its term loan (TL) B to 875 million U.S. dollars from 750 million U.S. dollars.

  • Alere acquires additional 5M shares of Axis-Shield.  // Medical Device Daily;10/3/2011, Vol. 15 Issue 188, p3 

    The article reports that an additional shares of Axis-Sheild stock were purchased by Alere which brings its total current ownership position to 21.98% of Axis-Sheild's issued and outstanding ordinary share capital.

  • Alere Taps HY Market for $450M. Sheahan, Matthew // High Yield Report;12/3/2012, p27 

    The article reports on the sale of a 450 million U.S. dollar bond in 7.25 percent senior notes by Alere of Waltham, Massachusetts due 2018.

  • Financings roundup.  // Medical Device Daily;11/29/2012, Vol. 16 Issue 231, p3 

    The article announces the intention of Alere to offer 450 million U.S. dollars of senior notes due 2018 through a private placement, subject to market and other conditions.

  • Alere Adds $450M to Bond Queue. Sheahan, Matthew // High Yield Report;12/3/2012, p16 

    The article reports that Alere, a Waltham, Massachusetts-based health care management company, is selling 450 million U.S. dollars in senior notes due 2018.

  • Agreements/contracts.  // Medical Device Daily;8/12/2011, Vol. 15 Issue 151, p3 

    The article reports on license agreement signed between VitaPath Genetics and Alere for VitaPath's spina bifida risk assessment assay.

  • Deals roundup.  // Medical Device Daily;12/2/2011, Vol. 15 Issue 230, p3 

    The article reports on the equity interest in Arriva Medical sold by Palm Beach Capital Fund III to Alere.

  • Financings roundup.  // Medical Device Daily;6/1/2011, Vol. 15 Issue 105, p2 

    The article reports on the launching of certain consent solicitations relating to the 9.0% senior subordinated notes of Alere due 2016, as well as the 8.625% senior subordinated notes due 2018 and 7.875% senior notes due 2016 of the company.

  • A Closer Look: STD/HIV Testing Devices.  // Clinical Lab Products;Jun2014, Vol. 44 Issue 6, p9 

    The article previews several sexually transmitted disease (STD) and HIV testing devices including the Alere Determine HIV-1/2 Ag/Ab Combo from Alere Inc., Bio-Rad's Droplet Digital polymerase chain reaction (ddPCR) system and the MultiCode-RTx HSV 1 and 2 kit tests for herpes simplex virus 1 and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics